Sealaska Corporation

Purpose: the Coronavirus Relief Fund Program Is Authorized by the Cares Act and Provides Funding for Necessary Expenditures Incurred Due to the Public Health Emergency With Respect to COVID-19; for Costs That Were Not Accounted for in the Government's Most Recently Approved Budget as of March 27, 2020; and for Costs That Were Incurred During the Period That Begins on March 1, 2020, and Ends on December 31, 2021. Activities to Be Performed: Treasury Will Make Direct Payments to State, Territorial, Tribal, and Eligible Local Governments ("eligible Entities") to Use the Funding for the Eligible Purposes Outlined in the Program Statute, and Treasury's Interpretive Guidance. End Goal/expected Outcomes: the Coronavirus Relief Fund Program Funding Will Assist With Expenditures Including, But Not Limited to, Provision of Grants to Small Businesses to Reimburse the Costs of Business Interruption Caused by Required Closures; Establish Temporary Public Medical Facilities and Other Measures to Increase COVID-19 Treatment Capacity, Including Related Construction Costs; Provision of COVID-19 Testing, Including Serological Testing; Establishing and Operating Public Telemedicine Capabilities for COVID-19-RELATED Treatment; Care Expenses for the Homeless Populations to Mitigate COVID-19 Effects and Enable Compliance With COVID-19 Public Health Precautions; Unemployment Insurance Costs Related to the COVID-19 Public Health Emergency If Such Costs Will Not Be Reimbursed by the Federal Government Pursuant to the Cares Act or Otherwise. Intended Beneficiaries: Essential Workers, Households, Small Businesses, Nonprofits, the Governments of the Eligible Entities, the General Public, Etc. Subrecipient Activities: Subrecipient Activity Includes, But Are Not Limited to, Carrying Out Grant Programs on Behalf of the Recipients.